Clinical presentation, diagnosis and management of Cryptococcus gattii cases: Lessons learned from British Columbia

Canadian Journal of Infectious Diseases and Medical Microbiology

Volumn 20, Issue 1, 2009, Pages 23-28

  Galanis, Eleni ^a,b   Hoang, Linda ^a,b   Kibsey, Pamela ^c   Morshed, Muhammad ^a,b   Phillips, Peter ^b,d  

^a BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c VANCOUVER ISLAND HEALTH AUTHORITY   (Canada)

^d ST PAUL S HOSPITAL   (Canada)

Author keywords

Case series; Cryptococcus gattii; Diagnosis; Treatment

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE;

ADULT; AGED; ANAMNESIS; ARTICLE; BRAIN INFECTION; CANADA; CASE REPORT; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID; CLINICAL FEATURE; CRYPTOCOCCOSIS; CRYPTOCOCCUS; DIAGNOSTIC IMAGING; FEMALE; FUNGAL STRAIN; FUNGUS ISOLATION; GENOTYPE; HUMAN; LUNG INFECTION; MALE; TREATMENT OUTCOME;

EID: 64849107840     PISSN: 17129532     EISSN: None     Source Type: Journal    
DOI: 10.1155/2009/719659     Document Type: Article

References (41)

1. Stephen C, Lester S, Black W, Fyfe M, Raverty S. Multispecies outbreak of cryptococcosis on southern Vancouver Island, British Columbia. Can Vet J 2002;43:792-4.
2. Kidd SE, Hagen F, Tscharke RL, et al. A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). Proc Natl Acad Sci USA 2004;101:17258-63.
3. BC Centre for Disease Control. BC Cryptococcus gattii surveillance summary, 1999-2006. (Version current at October 21, 2008).
4. Chayakulkeeree M, Perfect JR. Cryptococcosis. Infect Dis Clin North Am 2006;20:507-44.
5. Chen S, Sorrell T, Nimmo G, et al. Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Clin Infect Dis 2000;31:499-508.
6. Perfect JR, Casadevall A. Cryptococcosis. Infect Dis Clin N Am 2002;16:837-74.
7. Speed B, Dunt D. Clinical and host differences between infections with the two varieties of Cryptococcus neoformans. Clin Infect Dis 1995;21:28-34.
8. Sorrell TC. Cryptococcus neoformans variety gattii. Med Mycol 2001;39:155-68.
9. Lindberg J, Hagen F, Laursen A, Stenderup J, Boekhout T. Cryptococcus gattii risk for tourists visiting Vancouver Island, Canada. Emerg Infect Dis 2007;13:178-9.
10. MacDougall L, Fyfe M. Emergence of Cryptococcus gattii in a novel environment provides clues to its incubation period. J Clin Microbiol 2006;44:1851-2.
11. Bennett JE, Hospenthal DR. Persistence of cryptococcomas on neuroimaging. Clin Infect Dis 2000;31:1303-6.
12. Koneman EW, Roberts GD, eds. Practical Laboratory Mycology, 3rd edn. Baltimore: Williams and Wilkins, 1985:21.
13. Kaufman L, Blumer S. Cryptococcosis: The awakening giant. In: Proceedings of the Fourth International Conference on Mycoses, Brasilia, Brazil, June 1977. Washington, DC: Pan American Health Organization, 1977. (PAHO Scientific Publication no. 356).
14. Tanner DC, Weinstein MP, Fedorciw B, et al. Comparison of commercial kits for detection of cryptococcal antigen. J Clin Microbiol 1994;32:1680-4.
15. Stamm AM, Polt SS. False negative cryptococcal antigen test. JAMA 1980;244:1359.
16. Latex-cryptococcus antigen detection system REF CR1003, REF CR1004, REF CR1005, and Individual Reagents. Norman: IMMY Immuno-Mycologics Inc. (Package insert.)
17. Mera WG, Roberts GD. Algorithms for detection and identification of fungi. In: Murray PR, Baron EJ, et al, eds. Manual of Clinical Microbiology, 8th edn. ASM Press 2003:1668-76.
18. Kwon-Chung KJK, Polacheck I, Bennett JE. Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C). J Clin Microbiol 1982;15:535-7.
19. Brandt ME, Hutwagner LC, Kuykendall RJ, Pinner RW. Comparison of multilocus enzyme electrophoresis and random amplified polymorphic DNA analysis for molecular subtyping of Cryptococcus neoformans. The Cryptococcal Disease Active Surveillance Group. J Clin Microbiol 1995;33:1890-5.
20. Casadevall A, Freundlich L F, Marsh L, Scharff MD. Extensive allelic variation in Cryptococcus neoformans. J Clin Microbiol 1992;30:1080-4.
21. Currie BP, Freundlich L F, Casadevall A. Restriction fragment length polymorphism analysis of Cryptococcus neoformans isolates from environmental (pigeon excreta) and clinical sources in New York City. J Clin Microbiol 1994;32:1188-92.
22. Perfect JR, Ketabchi N, Cox GM, Ingram CW, Beiser CL. Karyotyping of Cryptococcus neoformans as an epidemiological tool. J Clin Microbiol. 1993;31:3305-9.
23. Yamamoto Y, Kohno S, Koga H, et al. Random amplified polymorphic DNA analysis of clinically and environmentally isolated Cryptococcus neoformans in Nagasaki. J Clin Microbiol 1995;33:3328-32.
24. Latouche GN, Huynh M, Sorrell TC, Meyer W. PCR-restriction fragment length polymorphism analysis of the phospholipase B (PLB1) gene for subtyping of Cryptococcus neoformans isolates. Appl Envir Microbiol 2003;69:2080-6.
25. Saag MS, Graybill RJ, Larsen RA, et al. Practice guidelines for the management of cryptococcal disease. Clin Infect Dis 2000;30:710-8.
26. Kerkering TM, Duma RJ, Shadomy S. The evolution of pulmonary cryptococcosis: Clinical implications from a study of 41 patients with and without compromising host factors. Ann Intern Med 1981;94:611-6.
27. Pappas G P, Perfect JR, Cloud GA et al. Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin Infect Dis 2001;33:690-9.
28. Brouwer AE, Rajanuwong A, Chierakul, et al. Combination antifungal therapies for HIV-associated cryptococcal meningitis: A randomized trial. Lancet 2004;363:1764-7.
29. Larsen RA, Leal MAE, Chan SL. Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS: A randomized trial. Ann Intern Med 1990;113:183-7.
30. van der Horst CM, Saag MS, Cloud GA, et al. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. N Engl J Med 1997;337:15-21.
31. Hamill RJ, Sobel J, El-Sadr W, et al. Randomized double-blind trial of AmBisome (liposomal amphotericin B) and amphotericin B in acute cryptococcal meningitis in AIDS patients. 39th Interscience Conference on Antimicrobial Agents and Chemotherapy; San Francisco, September 26 to 29, 1999.
32. Clemons K V, Stevens DA. Comparison of Fungizone, Amphotec, AmBisome, and Abelcet for treatment of systemic murine cryptococcosis. Antimicrob Agents Chemother 1998;42:899-902.
33. Sharkey PK, Graybill JR, Johnson ES, et al. Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDS. Clin Infect Dis 1996;22:315-21.
34. Graybill JR, Sobel J, Saag M, et al. Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. Clin Infect Dis 2000;30:47-54.
35. Liliang PC, Liang CL, Chang WN, et al. Shunt surgery for hydrocephalus complicating cryptococcal meningitis in human immunodeficiency virus-negative patients. Clin Infect Dis 2003;37:673-8.
36. Phillips P, Chapman K, Sharp M, et al. Dexamethasone in Cryptococcus gattii central nervous system infection. AMMI Canada- CACMID Conference, Vancouver, February 27 to March 2, 2008. (Abst K2).
37. Lane M, McBride J, Archer J. Steroid responsive late deterioration in Cryptococcus neoformans variety gattii meningitis. Neurology 2004;63:713-14.
38. Einsiedel L, Gordon DL, Dyer JR. Paradoxical inflammatory reaction during treatment of Cryptococcus neoformans var. gattii meningitis in an HIV-seronegative woman. Clin Infect Dis 2004;39:e78-82.
39. Garrity JA, Herman DC, Imes R, Fries P, Hughes CF, Campbell RJ. Optic nerve sheath decompression for visual loss in patients with acquired immunodeficiency syndrome and cryptococcal meningitis with papilledema. Am J Ophthalmol 1993;116:472-8.
40. MacDougall L, Kidd S, Galanis E, et al. Spread of Cryptococcus gattii in British Columbia, Canada and its detection in the Pacific Northwest, USA. Emerg Infect Dis 2007;13:42-50.
41. Upton A, Fraser JA, Kidd SE, et al. First contemporary case of human infection with Cryptococcus gattii in Puget Sound: Evidence for spread of the Vancouver Island outbreak. J Clin Microbiol 2007;45:3086-8.